Cytek Biosciences (CTKB) Short-term Investments (2020 - 2024)

Cytek Biosciences has reported Short-term Investments for 4 years, with the latest figure at $29000.0 in Q4 2024.

• For the quarter ending Q4 2024, Short-term Investments fell 91.24% year-over-year to $29000.0; the trailing twelve-month figure through Dec 2024 stood at $29000.0 (down 91.24% YoY), and the FY2024 full-year result was $29000.0, down 91.24% from the prior year.
• Short-term Investments for Q4 2024 stood at $29000.0, down from $31000.0 in the prior quarter.
• The five-year high for Short-term Investments was $2.9 million in Q1 2023, with the low at $29000.0 in Q4 2024.
• Historically, Short-term Investments has averaged $940750.0 across 4 years, with a median of $365500.0 in 2023.
• The largest YoY upside for Short-term Investments was 86.29% in 2024 against a maximum downside of 91.24% in 2024.
• Cytek Biosciences' Short-term Investments stood at $888000.0 in 2020, then surged by 226.46% to $2.9 million in 2022, then tumbled by 88.58% to $331000.0 in 2023, then tumbled by 91.24% to $29000.0 in 2024.
• The last three Short-term Investments figures came in at $29000.0 (Q4 2024), $31000.0 (Q3 2024), and $30000.0 (Q2 2024), per Business Quant data.